Search for: "Boehringer Ingelheim Pharmaceutical, Inc" Results 61 - 80 of 90
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2012, 1:15 pm by Tom Lamb
New Case Report About Routine Fall Involving An Elderly Patient That Results In Fatal Irreversible Brain Hemorrhage (Posted by Tom Lamb at DrugInjuryWatch.com)  Pradaxa® is the name under which Boehringer Ingelheim Pharmaceuticals, Inc. markets a prescription anticoagulant medication generically called dabigatran.   [read post]
14 Mar 2012, 10:42 am
Boehringer Ingelheim Pharmaceuticals Inc., et al.; U.S. [read post]
12 Jan 2012, 4:21 am
The IPKat has always been unhappy at the bit in Case C-348/04 Boehringer Ingelheim KG v Swingward Ltd: where the Court of Justice of the European Union said: "Where a parallel importer has failed to give prior notice to the trade mark proprietor concerning a repackaged pharmaceutical product, he infringes that proprietor’s rights on the occasion of any subsequent importation of that product, so long as he has not given the proprietor such notice. [read post]
28 Jul 2011, 11:19 am by Bexis
Boehringer Ingelheim Pharmaceuticals, No. 10-3129, slip op. (8th Cir. [read post]
31 Jan 2011, 8:10 am by Stefanie Levine
Terminal Disclaimers and Section 121 Boehringer Ingelheim International GmbH v. [read post]
19 Dec 2010, 9:44 am
--Naik v Boehringer Ingelheim Pharm, Inc., 7thCir, November 22, 2010, No. 09-2960: Summary judgment upheld for employer after 53-year-old former pharmaceutical sales rep failed to show that termination based on falsification of call records, was pretext for age and national origin (Indian) discrimination in violation of the Age Discrimination in Employment Act (ADEA) and Title VII.The employer's legitimate non-discriminatory reason (LNDR) was pretty damning… [read post]
17 Dec 2010, 11:05 am by Bexis
Boehringer Ingelheim Pharmaceuticals, Inc., slip op. (8th Cir. [read post]
9 Dec 2010, 3:53 am by Bob Kraft
Specifically, "Boehringer Ingelheim GmbH's Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
9 Dec 2010, 2:49 am by Bob Kraft
Specifically, “Boehringer Ingelheim GmbH’s Roxane Inc. will pay $280 million, Abbott will pay $126.5 million and B. [read post]
7 Dec 2010, 2:43 am by Ben Vernia
As for Roxane: Roxane is paying $280 million to resolve claims against it and related entities (Roxane Laboratories Inc., Boehringer Ingelheim Corp. and Boehringer Ingelheim Pharmaceuticals Inc.). [read post]
31 May 2010, 8:52 pm by Patent Docs
Intervet Inc. et al. 1:10-cv-00435; filed May 25, 2010 in the District Court of Delaware • Plaintiff: Wyeth LLC • Defendants: Intervet Inc. d/b/a Intervet/Schering-Plough Animal Health; Boehringer Ingelheim Vetmedica Inc. [read post]
29 Dec 2009, 9:09 pm by ipdeals
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]
29 Dec 2009, 9:09 pm by ipdeals
Director Team Leader, International Business Development, Pfizer Bill Bertrand, Senior Vice President, Legal Affairs, General Counsel and Corporate Compliance Officer, MedImmune Adelene Perkins, President and Chief Business Officer, Infinity Pharmaceuticals Michael Leonetti; Head, Health Care Partnerships, Boehringer Ingelheim David Low, Managing Director, Lazard Sanj Singh, CEO, Ade Therapuetics Here is a link to the event where you can get more… [read post]